Clinical Trials Browser

Phase EARLY_PHASE1 × Not yet recruiting × pembrolizumab × Clear all

NCT06212388 2024-01-25

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Phase EARLY_PHASE1 Not yet recruiting

Melanoma